Welcome to our dedicated page for Tivic Health Systems news (Ticker: $TIVC), a resource for investors and traders seeking the latest updates and insights on Tivic Health Systems stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Tivic Health Systems's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Tivic Health Systems's position in the market.
Rhea-AI Summary
Tivic Health® Systems, Inc. announced its financial results for 2023, highlighting a decrease in revenue but improved gross profit. The company focused on streamlining operations, reducing costs, and investing in new clinical programs. Despite a net loss of $8.2M, Tivic received accolades for innovation and bioelectronic medicine. The company conducted a pilot clinical study on vagus nerve stimulation and plans to create new value paths for shareholders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-17.24%
Tags
-
News
Rhea-AI Summary
Tivic Health® Systems, Inc. (TIVC) will announce its 2023 year-end financial results on March 25, 2024, through a pre-recorded conference call and webcast. The event will provide insights into the company's performance and financial standing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.79%
Tags
-
Rhea-AI Summary
Tivic Health Systems, Inc. completes enrollment in pilot clinical study for non-invasive vagus nerve stimulation, aiming to enhance effectiveness and safety in treating neurologic and psychiatric disorders. The company is expanding its bioelectronic portfolio to new clinical uses beyond existing products.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.78%
Tags
Rhea-AI Summary
Tivic Health® Systems, Inc. (TIVC) has entered a limited exclusive distribution agreement with a Top 10 Medical Equipment Distributor and Supplier in the nation. The agreement grants the new Distributor exclusive distribution rights for Tivic Health’s ClearUP product for major retailers like Walmart, Target, eBay, and Kroger, as well as non-exclusive rights in other specified online channels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.76%
Tags
-
Rhea-AI Summary
Tivic Health Systems, a health technology company listed on Nasdaq as TIVC, has announced the launch of Tivic ClearUP 2.0. This new generation of the bioelectronic medicine device features a new chip for power management, providing faster charge and longer battery life. ClearUP 2.0 is FDA-approved and clinically proven to relieve sinus pain, pressure, headaches, and congestion caused by colds, flu, and allergies. Clinical trials have shown significant improvement in congestion symptoms, pain relief, and patient preference for ClearUP over other sinus treatments.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.95%
Tags
-
Rhea-AI Summary
Tivic Health® Systems, Inc. (Nasdaq: TIVC) announced a 71% increase in gross profit and a 30% decrease in operating expenses in Q3 2023. Revenue was $282 thousand, with a 38% gross margin. The company also achieved various milestones, including new partnerships, distribution agreements, and patent allowance. A reverse stock split led to regained NASDAQ compliance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.76%
Tags
Rhea-AI Summary
Tivic Health® Systems, Inc. (Nasdaq: TIVC) will release its Q3 2023 financial results via pre-recorded conference call and webcast on November 14, 2023. The teleconference details and webcast link are provided for accessibility.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.52%
Tags
-
Rhea-AI Summary
Tivic Health has signed an agreement with InStep Health to introduce its bioelectronic sinus device, ClearUP, to over 2,500 healthcare providers and their patients. The 4-month program aims to educate HCPs and increase patient awareness of ClearUP during allergy, cold, and flu seasons. This could potentially lead to increased sales and recommendations for the product.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.49%
Tags
-
Rhea-AI Summary
Tivic Health has regained compliance with NASDAQ's minimum bid price requirement, ensuring continued listing and trading on the Nasdaq Capital Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.38%
Tags
Rhea-AI Summary
Tivic Health has entered into a non-exclusive agreement with AmerisourceBergen to make its products available on AmerisourceBergen's third-party marketplace. Tivic's ClearUP bioelectronic sinus pain relief device will be offered on the marketplace, which aims to create a faster and more convenient shopping experience for retail pharmacy customers. This partnership is seen as a strategic step in expanding Tivic's customer reach and product awareness with independent retail pharmacies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.01%
Tags
Tivic Health Systems, Inc.
Nasdaq:TIVC
TIVC Rankings
TIVC Stock Data
1.55M
1.43M
1.42%
4.23%
3.18%
Surgical and Medical Instrument Manufacturing
Manufacturing
United States of America
HAYWARD
About TIVC
the tivic health team is dedicated to exploring the use of microcurrents for therapeutic benefit and pioneering advances in bioelectronic medicine. our initial focus is delivering sinus pain relief. synus is new alternative for temporary relief of sinus pain and pressure. www.tivichealth.com/synus currently, the most recommended treatment for those experiencing recurring sinus pain is daily flushing of the nose with salt water. we believe people should have access to relief without pills, sprays and flushes.